(Reuters) – Bristol Myers Squibb said on Thursday its drug Orencia did not show statistically significant results in speeding up recovery in COVID-19 patients versus a placebo in a late-stage study.
(Reporting by Leroy Leo in Bengaluru; Editing by Devika Syamnath)
